Jaguar Health, Inc.: Jaguar Health Provides Company Updates and Reports 2022 Third Quarter Financials
Prescription product net revenue of approximately $3.1 million in Q3 2022 increased 8.2% over Q2 2022 and increased approximately 412% over prescription product net revenue in Q3 2021Core initiatives:OnTarget